Also Read: Low-dose colchicine may help prevent CV events in patients with type 2 diabetes and MI: COLCOT trial The study results were published in the European Heart Journal. The FDA has recently ...

Nas Celebrates 30 Years of 'Illmatic' With New Capsule Collection ...

and stable coronary artery disease who received colchicine 0.5 mg daily in addition to standard secondary prevention therapies compared with standard medical therapy alone. 1,2 Although these data ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...